doi: 10.2337/dc14-2689 Summary Keywords GLP-1 receptor agonist, insulin therapy, type 2 diabetes, switching to GLP-1 receptor agonist, type 2 diabetes inadequately controlled with insulin therapy Citation Kim Y, Huh JH, Lee M, Kang ES, Cha B-S and Lee B-W (2022) Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
Mogana Rajagopal, [email protected] This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Contact pharmacies if there is any doubt that medication may have a fraudulent label
2021, Jun;54(6):125775.e8 Shoraka S, Samarasinghe AE, Ghaemi A, Mohebbi SR
Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies
Physicians and organizations have been promoting diet, exercise and plant based diets for yearsbut the public is enamored with other stuff, and many dont engage in sufficient exercise to make a difference
